https://www.selleckchem.com/products/cp-43.html
2%) of the participants achieving it after only 8 weeks of administration. After 16 weeks, LDL-C decreased by 45.8±16.7% ( 0.001) from the baseline, and total cholesterol (33.2±10.9%; 0.001), triglyceride (24.2±37.5%; =0.001), and apolipoprotein B (34.9±15.6%; 0.001) also significantly decreased. Blood glucose and liver enzyme levels slightly increased, but none of the participants developed serious adverse events that would cause them to prematurely withdraw from the clinical trial. 20 and 40 mg atorvastatin was effective and